Showing posts with label pancreatic tumor. Show all posts
Showing posts with label pancreatic tumor. Show all posts

Sunday, December 25, 2011

Standard Treatment Options for Pancreatic Cancer



Unfortunately early symptoms of pancreatic cancer are very difficult to detect, therefore this form of cancer is known as a silent cancer. The pancreas, (an organ that is located in the lower portion of a person’s stomach), is essential for healthy digestive functioning. When the pancreas is acting normally, it creates and secrets special enzymes that help metabolize carbohydrates and other foods. The pancreas is used in the body to help release insulin and other essential hormones however the danger lies in the extra insulin that is release which can cause complication to the body which can cause death long before the cancer takes mortal effect.

If a person has pancreatic cancer, the very organ that helps keep them healthy becomes lethal. This is because with pancreatic cancer, the pancreas becomes ridden with tumors - abnormal cells that develop from cells that were originally normal. If they are not killed off by pancreatic cancer treatments, they will multiply, wreaking havoc first to the pancreas itself then spreading to other parts of the body.

Chances of Recovery

The prognosis (chance of recovery) and treatment options depend on the following:
  • Whether or not the tumor can be removed by surgery.
  • The stage of the cancer (the size of the tumor and whether the cancer has spread outside the pancreas to nearby tissues or lymph nodes or to other places in the body).
  • The patient’s general health.
  • Whether the cancer has just been diagnosed or has recurred (come back).
Pancreatic cancer can be controlled only if it is found before it has spread, when it can be removed by surgery. If the cancer has spread, palliative treatment can improve the patient's quality of life by controlling the symptoms and complications of this disease.

Treatment Options for Pancreatic Cancer

Different types of treatment are available for patients with pancreatic cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

Standard Treatment for Pancreatic Cancer

We will review the three types of standard treatment options for pancreatic cancer in this post.

Surgery

One of the following types of surgery may be used to take out the tumor:
  • Whipple procedure: Whipple procedure (pancreatoduodenectomy) is considered if pancreatic cancer is located in the head of the pancreas. It involves removing the head of pancreas, as well as a portion of small intestine (duodenum), gallbladder and part of bile duct. Part of the stomach may be removed as well. The surgeon reconnects the remaining parts of your pancreas, stomach and intestines to allow you to digest food. Enough of the pancreas is left to produce digestive juices and insulin. Whipple surgery carries a risk of infection and bleeding. After the surgery, some people experience nausea and vomiting that can occur if the stomach has difficulty emptying (delayed gastric emptying). Patients should expect a long recovery after a Whipple procedure. They might spend 10 days or more in the hospital and then recover for several weeks at home.
  • Total pancreatectomy: Total pancreatectomy targets removing the whole pancreas, part of the stomach, part of the small intestine, the common bile duct, the gallbladder, the spleen, and nearby lymph nodes.
  • Distal pancreatectomy: Distal pancreatectomy is the surgical procedure, when the body and the tail of the pancreas and usually the spleen are removed. This surgery carries a certain risk of bleeding and infection.
If the cancer has spread and cannot be removed, the following types of palliative surgery may be done to relieve symptoms:
  • Surgical biliary bypass: If cancer is blocking the small intestine and bile is building up in the gallbladder, a biliary bypass may be done. During this operation, the doctor will cut the gallbladder or bile duct and sew it to the small intestine to create a new pathway around the blocked area.
  • Endoscopic stent placement: If the tumor is blocking the bile duct, surgery may be done to put in a stent (a thin tube) to drain bile that has built up in the area. The doctor may place the stent through a catheter that drains to the outside of the body or the stent may go around the blocked area and drain the bile into the small intestine.
  • Gastric bypass: If the tumor is blocking the flow of food from the stomach, the stomach may be sewn directly to the small intestine so the patient can continue to eat normally.
Research shows pancreatic cancer surgery tends to cause fewer complications when done by experienced surgeons. Patients should not hesitate to ask about the surgeon's experience with pancreatic cancer surgery. If they have any doubts, they should seek for a second opinion.

Radiation therapy

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:
  • External radiation therapy uses a machine outside the body to send radiation toward the cancer.
  • Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.
The way the radiation therapy is given depends on the type and stage of the cancer being treated. Patients may receive radiation treatments before or after cancer surgery, often in combination with chemotherapy. Or, the doctor may recommend to a patient a combination of radiation and chemotherapy treatments when the cancer can't be treated surgically.

Chemotherapy

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy).

The way the chemotherapy is given depends on the type and stage of the cancer being treated. Chemotherapy can also be combined with radiation therapy (chemoradiation). Chemoradiation is typically used to treat cancer that has spread beyond the pancreas, but only to nearby organs and not too distant regions of the body. This combination may also be used after surgery to reduce the risk that pancreatic cancer may recur.

In people with advanced pancreatic cancer, chemotherapy may be combined with targeted drug therapy.

Targeted therapy

Targeted therapy uses drugs that attack specific abnormalities within cancer cells. The targeted drug erlotinib (Tarceva) blocks chemicals that signal cancer cells to grow and divide. Erlotinib is usually combined with chemotherapy for use in people with advanced pancreatic cancer.

Other targeted drug treatments are under investigation in clinical trials.


Sources and Additional Information:

Wednesday, November 23, 2011

Direct Injection of PANVAC Vaccine in Pancreatic Tumor


PANVAC Vaccines

Pancreatic cancer is an extremely aggressive type of cancer, causing most of the affected patients to succumb to the disease in a short period of time, since early diagnostics is not available, and when cancer is identified, it might be too late for the successful recovery for the disease. Current standard cancer treatments such as surgery, chemotherapy and radiotherapy are not effective against this disease as this is a treatment unmanageable disease. The lifetime risk of developing pancreatic cancer is about one in 76 for both men and women and there is a five-year survival rate of only five percent, despite advancements in surgery, chemotherapy and radiation treatment.

Therefore, general vaccination approach as the promising treatment strategy is currently under investigation in multiple research centers. What used to be a relatively esoteric line of research – immunotherapy for cancer -- has become mainstream. In fact, there are so many companies and institutions involved in various aspects of cancer vaccine research that the Albert B. Sabin Vaccine Institute has organized the Cancer Vaccine Consortium to help accelerate the development and licensure of these immunotherapies. Some biotech firms have been investigating cancer vaccines for decades now, and the lessons they've learned over time inform the burgeoning field as it moves forward.

Beginning 2004, Cambridge, Mass.-based Therion Biologics Corporation submitted its application to the FDA to conduct a Phase III trial under a special protocol assessment, the company prepared published data of 12 different randomized pancreatic cancer trials.

"Median survival of that group was three months, no matter what the agent used was," said Mark Leuchtenberger, president and CEO of Therion. "Unfortunately, I think what we've done is just confirm those data right now."

The Phase III trial, begun in May 2004, enrolled 255 patients with advanced pancreatic cancer and was aiming to show a 50 percent improvement - about a two-month extension - in survival over control chemotherapy. The study was designed from two Phase I studies that showed a median overall survival of more than six months.

Panvac-VF is designed to stimulate the immune system to target anddestroy cancer cells expressing carcinoembryonic antigen and mucin-1, which are found on more than 90 percent of pancreatic tumor cells. The vaccine incorporates Therion's triad of co-stimulatory molecules (B7.1, ICAM-1 and LFA-3) to enhance and sustain a targeted immune response.

However, the trial was NOT successful, and the expected positive outcomes for the patients have not been proven.

Vaccine Direct Injection in Pancreatic Tumor

In spite of the previous failure of the mainstream clinical trial for pancreatic cancer research, more trials were performed for other types of cancer with this vaccine. And the new boost was given this year with revealing early results of a clinical trial being conducted at The Cancer Institute of New Jersey.

Previous studies by scientists at CINJ have shown that injecting a vaccine and other immunity-producing drugs into a cancer tumor itself — rather than the traditional site of the skin — can result in a reversal of the traditional immune blockade and the development of specific immunity to the tumor. This body-wide tumor-specific immunity has the potential of blocking the growth of the original tumor as well as eliminating small deposits of tumor that can cause the cancer to spread. Stemming from this research is a clinical trial that is the focus of this poster presentation. The study by CINJ investigators further tests this vaccine strategy, designed to harness the body’s own immune system to fight cancer.

Researchers are utilizing two types of PANVAC, containing gene additives that might stimulate a person’s immune system to recognize and develop an immune response to the disease.

PANVAC-V, which uses the same virus as the smallpox vaccine, is a live but weakened vaccinia vaccine (meaning the virus can still multiply) that is given in the arm.

PANVAC-F (a live Fowlpox virus that cannot multiply) is injected into the arm and into the tumor itself. Direct tumor injection takes place through a procedure known as endoscopic ultrasound, in which a scope is inserted through the mouth and into the stomach.

During the first phase of the study, which looked at six participants whose cancer could not be removed through surgery, patients were evaluated for toxicity, tumor progression and the presence of tumor markers for pancreatic cancer. Two patients were removed from the study after two weeks due to rapid disease progression. Of the remaining four patients, three had received gemcitabine – a standard treatment for pancreatic cancer – after receiving vaccination treatment. The other patient was treated with gemcitabine, followed by capecitabine and radiation, prior to the vaccination regimen and received no other treatment after.

Of these four patients, all were shown to have clinically stable disease after 15 months, 13 months, 12 months and nine months respectively. The second part of the trial is accruing additional participants, who are being given a higher dosage of PANVAC-F during direct injection of the tumor.

Elizabeth Poplin, MD, medical oncologist at CINJ and professor of medicine at UMDNJ-Robert Wood Johnson Medical School, is the lead researcher on the study, which is sponsored by the National Cancer Institute (NCI). “By utilizing the body’s own defenses in this way in combination with traditional therapies, we have an opportunity to better identify more effective treatment and management options for this disease, which unfortunately only has a five-year, five-percent survival rate,” said Dr. Poplin.



Sources and Additional Information:

Wednesday, October 26, 2011

Biopsy for Pancreatic Cancer Diagnosing and Staging


Imaging tests are important in diagnosing suspected pancreatic cancer, but they cannot determine with 100% certainty if an abnormal mass is cancer or the type of cancer. During a biopsy, a small portion of a suspicious mass or cyst is removed and examined under a microscope for the presence of cancerous tissue. A biopsy can provide your doctor with an exact diagnosis. However, it is important to note that obtaining a conclusive tissue sample can be difficult. If cancerous tissue is found, the shape, size, and arrangement of the cells may help your doctor determine the type and stage of pancreatic cancer present.

If you have a cancer that is not removable with surgery, your specialist may want to biopsy it so that you can go on to have cancer treatment to try to slow down its growth. If all your other test results point to cancer and your consultant thinks there is no doubt that this is what you have, you may not need a biopsy before you have treatment.

There are several biopsy methods. Depending on the location of the mass and your personal health history, your doctor may use any of the following methods to provide the most accurate diagnosis.

Fine Needle Aspiration (FNA)

FNA is the most common biopsy procedure due to its safety and the reliability of its results. There are two ways to perform an FNA biopsy of the pancreas, either percutaneously (through the skin) or EUS-guided (with endoscopic ultrasound assistance).

During a percutaneous fine-needle aspiration, a local anesthetic and a cleaning solution are applied on the skin.  Then, a thin needle is inserted through the abdominal wall while the doctor uses the image from a CT scan or ultrasound to guide placement of the needle.  The needle is directed into the pancreas so that cells can be removed from the tumor.

The EUS-guided fine-needle aspiration method involves passing the needle down the throat through a special endoscope during an endoscopic ultrasound (EUS) imaging procedure.  This process involves imaging the tumor with ultrasound and inserting a thin needle through the stomach or duodenal wall immediately next to the pancreas.  Unlike percutaneous FNA, there is no pain with EUS-guided FNA.  EUS-guided fine-needle aspiration performed by a specially-trained and experienced doctor has been shown to be the most accurate biopsy method for the pancreas.

Brush Biopsy

In a brush biopsy, a small brush is inserted through the endoscope during an ERCP procedure and directly into your bile duct or pancreatic duct. Cells rub off onto the brush and can be examined using a microscope. However, the chance of getting a conclusive diagnosis using ERCP is low compared to FNA.

Forceps Biopsy

In a forceps biopsy, forceps are passed through the endoscope and a small piece of tissue is removed.  A tissue sample can also be taken during surgery.

Laparoscopy

Laparoscopy is a procedure in which a small camera attached to a thin, lighted tube is inserted directly into the abdominal cavity through a small incision. It is performed with the patient under general anesthesia. This means the patient is completely asleep during the procedure and does not respond to verbal or physical prompts. By manipulating the camera, the doctor can directly view the pancreas and its surrounding organs. Sometimes gas is pumped into the abdomen to make it swell and give more room for your doctor to look around. This gas will not do any harm and will gradually disperse and disappear after the test. Your doctor may use an ultrasound through the laparoscope. This will help to show exactly where the cancer is, so that your doctor can take a biopsy more accurately. A tissue biopsy can be taken by passing a pair of forceps through the laparoscope. After this test is over, you will have stitches or steristrips holding the incisions closed. They will heal within a week or so.

Laparotomy

If your disease cannot be diagnosed any other way, you will have an operation called a laparotomy. This is an operation to open the abdomen and take a tissue sample from the pancreas. This is not often done these days. Laparoscopy is usually done instead because it is a much smaller operation. You have to come into hospital for a laparotomy and stay in for a few days afterwards. Some surgeons will send the biopsy to the laboratory while you are still under anesthetic. If they get a positive diagnosis, they may continue to do the surgery you need for your cancer. Laparotomy is now rarely recommended as doctors prefer using Laparoscopy instead.

Most doctors who treat pancreatic cancer try to avoid surgery unless imaging tests suggest that an operation might be able to remove all of the visible cancer. Even after doing imaging tests and laparoscopy, there are times when the surgeon begins an operation with the intent of removing the cancer but finds during surgery that it has spread too far to be removed completely. In these cases, a sample of the cancer is taken only to confirm the diagnosis, and the rest of the planned operation is stopped.


Sources and Additional Information:

Related Posts Plugin for WordPress, Blogger...